Clinical trial
Oxytocin Substitution Therapy in Patients With AVP Deficiency (Central Diabetes Insipidus)
NCT06036004 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oxytocin Substitution Therapy in Patients With AVP Deficiency (Central Diabetes Insipidus)
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 8, 2024
- Completion date
- October 31, 2026
- Enrollment
- 112 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
central diabetes insipidus (cdi)